Pulse Economics Pty Ltd

Pulse Economics is a market access advisory firm driving healthcare innovation in Australia. We help pharmaceutical and medtech companies navigate the value-driven healthcare landscape and accelerate patient access to innovative solutions.

Our mission is to lead medtech commercialisation through strategic partnerships and evidence-based approaches.

We support clients across four key areas:

• R&D planning – designing clinical and real-world evidence strategies to support market authorisation and penetration
• market access – guiding reimbursement for PBS, MBS, NIP and LSDP to optimise pricing and patient access
• growth strategy – crafting commercialisation plans for early-stage ventures and established firms
• data analytics – delivering meta-analyses, survival studies and modelling to inform strategic decisions.

We help businesses commercialise AI-based medtech in Australia. Our approach includes:

• strategic consulting – assessing business needs and designing tailored adoption strategies
• market access – securing funding for AI-enabled solutions and aligning with reimbursement pathways
• growth strategy – scaling AI healthcare solutions and managing product lifecycles.

We guide clients through collaborative onboarding, training and continuous support. Our integration with CI/CD tools ensures AI adoption fits seamlessly into existing workflows. By aligning innovation with business priorities, compliance needs and quality goals, Pulse Economics helps clients deliver reliable healthcare solutions and achieve sustainable growth.